A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma

✍ Scribed by Hollebecque, A.; Deutsch, E.; Massard, C.; Gomez-Roca, C.; Bahleda, R.; Ribrag, V.; Bourgier, C.; Lazar, V.; Lacroix, L.; Gazzah, A.; Varga, A.; Baere, T.; Beier, F.; Kroesser, S.; Trang, K.; Zenke, F. T.; Klevesath, M.; Soria, Jean-Charles

• Book ID: 121607924
• Publisher: Springer US
• Year: 2013
• Tongue: English
• Weight: 445 KB
• Volume: 31
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-013-0026-9